Utama › Kolitis Ulseratif › Kentucky
Kajian klinikal Kolitis Ulseratif di Kentucky
13 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi di Kentucky.
Bandar di Kentucky
Teks kajian rasmi (Bahasa Inggeris)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284144, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-State Gastroenterology Associates, Crestview Hills
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Louisville
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 030, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07012395A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Tri-State Gastroenterology Assoc, Crestview Hills
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Health Partners, Louisville
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Louisville, Louisville
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Tri-State Gastroenterology Assoc, Crestview Hills
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kentucky Hospital/UK Albert B. Chandler Hospital - Site Number: 8400058, Lexington
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07184996Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Louisville, Louisville
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 8 Jan 2026 · NCT05987852Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.